Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression
-
Published:2022-05-23
Issue:11
Volume:29
Page:2288-2302
-
ISSN:1350-9047
-
Container-title:Cell Death & Differentiation
-
language:en
-
Short-container-title:Cell Death Differ
Author:
Luk Ian Y., Jenkins Laura J., Schoffer Kael L., Ng Irvin, Tse Janson W. T., Mouradov Dmitri, Kaczmarczyk Stanislaw, Nightingale Rebecca, Burrows Allan D.ORCID, Anderson Robin L., Arango Diego, Dopeso HiginioORCID, Croft Larry, Richardson Mark F., Sieber Oliver M., Liao Yang, Mooi Jennifer K., Vukelic Natalia, Reehorst Camilla M., Afshar-Sterle Shoukat, Whitehall Vicki L. J., Fennell LochlanORCID, Abud Helen E.ORCID, Tebbutt Niall C., Phillips Wayne A.ORCID, Williams David S., Shi Wei, Mielke Lisa A., Ernst MatthiasORCID, Dhillon Amardeep S., Clemons Nicholas J.ORCID, Mariadason John M.ORCID
Abstract
AbstractColorectal cancers (CRCs) often display histological features indicative of aberrant differentiation but the molecular underpinnings of this trait and whether it directly drives disease progression is unclear. Here, we identify co-ordinate epigenetic inactivation of two epithelial-specific transcription factors, EHF and CDX1, as a mechanism driving differentiation loss in CRCs. Re-expression of EHF and CDX1 in poorly-differentiated CRC cells induced extensive chromatin remodelling, transcriptional re-programming, and differentiation along the enterocytic lineage, leading to reduced growth and metastasis. Strikingly, EHF and CDX1 were also able to reprogramme non-colonic epithelial cells to express colonic differentiation markers. By contrast, inactivation of EHF and CDX1 in well-differentiated CRC cells triggered tumour de-differentiation. Mechanistically, we demonstrate that EHF physically interacts with CDX1 via its PNT domain, and that these transcription factors co-operatively drive transcription of the colonic differentiation marker, VIL1. Compound genetic deletion of Ehf and Cdx1 in the mouse colon disrupted normal colonic differentiation and significantly enhanced colorectal tumour progression. These findings thus reveal a novel mechanism driving epithelial de-differentiation and tumour progression in CRC.
Funder
Department of Health | National Health and Medical Research Council Cancer Council Victoria
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Molecular Biology
Reference40 articles.
1. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med. 2000;124:979–94. 2. Arango D, Al-Obaidi S, Williams DS, Dopeso H, Mazzolili R, Corner G, et al. Villin expression is frequently lost in poorly differentiated colon cancer. Am J Pathol. 2012;180:p1509–21. 3. Dow LE, O’Rourke KP, Simon J, Tschaharganeh DF, van Es JH, Clevers H, et al. Apc restoration promotes cellular differentiation and reestablishes crypt homeostasis in colorectal cancer. Cell. 2015;161:1539–52. 4. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Meyerhardt JA, Loda M, et al. CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer. Gut. 2009;58:90–6. 5. Zong L, Abe M, Ji J, Zhu W-G, Yu D. Tracking the correlation between CpG island methylator phenotype and other molecular features and clinicopathological features in human colorectal cancers: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2016;7:e151.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|